Novel Therapies Targeting Endometriosis

被引:65
作者
Taylor, Hugh S. [1 ]
Osteen, Kevin G. [2 ]
Bruner-Tran, Kaylon L. [2 ]
Lockwood, Charles J. [1 ]
Krikun, Graciela [1 ]
Sokalska, Anna [3 ]
Duleba, Antoni J. [3 ]
机构
[1] Yale Univ, Dept Obstet & Gynecol & Reprod Sci, New Haven, CT USA
[2] Vanderbilt Univ, Dept Obstet & Gynecol & Womens Hlth, Nashville, TN USA
[3] Univ Calif Davis, Dept Obstet & Gynecol, Sacramento, CA 95817 USA
关键词
Endometriosis; ICON; tissue factor; statins; stem cells; SERM; SPRM; ENDOTHELIAL GROWTH-FACTOR; MATRIX-METALLOPROTEINASE EXPRESSION; ESTROGEN-RECEPTOR MODULATORS; TISSUE FACTOR; STEM-CELLS; IN-VITRO; PROTEIN PRENYLATION; PERITONEAL-FLUID; STROMAL CELLS; TUMOR-CELLS;
D O I
10.1177/1933719111410713
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometriosis is an often painful disorder in which the endometrial glands and stroma grow outside the uterus. The disease affects women's quality of life and is a common cause of infertility. In this review, we describe promising new developments in the field based on in vitro assays and rodent models, each of which has the potential to be beneficial in the treatment of this disease. We will specifically describe the role of anti-inflammatory drugs, selective estrogen, or progesterone modulators, statins, antiangiogenic agents, and the potential for targeting stem cells as likely methods to hone in and eliminate endometriosis. The most promising of these potential therapies are currently slated for further testing in both rodent and nonhuman primate trials.
引用
收藏
页码:814 / 823
页数:10
相关论文
共 108 条
[101]   Cellular antioxidant effects of atorvastatin in vitro and in vivo [J].
Wassmann, S ;
Laufs, U ;
Müller, K ;
Konkol, C ;
Ahlbory, K ;
Bäumer, AT ;
Linz, W ;
Böhm, M ;
Nickenig, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (02) :300-305
[102]  
Weber M S, 2007, Int MS J, V14, P93
[103]   Endometriosis: A genetic disease [J].
Wenzl, R ;
Kiesel, L ;
Huber, JC ;
Wieser, F .
DRUGS OF TODAY, 2003, 39 (12) :961-972
[104]   Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms [J].
Wolberg, AS ;
Monroe, DM ;
Roberts, HR ;
Hoffman, MR .
BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (04) :201-210
[105]   HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation [J].
Xu, Hanshi ;
Zeng, Lixia ;
Peng, Hui ;
Chen, Sheldon ;
Jones, Jonathan ;
Chew, Teng-Leong ;
Sadeghi, Mehran M. ;
Kanwar, Yashpal S. ;
Danesh, Farhad R. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 291 (05) :F995-F1004
[106]   TRANSPLANTATION OF NORMAL AND ECTOPIC HUMAN ENDOMETRIAL TISSUE INTO ATHYMIC NUDE-MICE [J].
ZAMAH, NM ;
DODSON, MG ;
STEPHENS, LC ;
BUTTRAM, VC ;
BESCH, PK ;
KAUFMAN, RH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (06) :591-597
[107]   Protein prenylation: Molecular mechanisms and functional consequences [J].
Zhang, FL ;
Casey, PJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :241-269
[108]   Cigarette smoke inhibits recruitment of bone-marrow-derived stem cells to the uterus [J].
Zhou, Yuping ;
Gan, Ye ;
Taylor, Hugh S. .
REPRODUCTIVE TOXICOLOGY, 2011, 31 (02) :123-127